One of the most recent studies out of Greece involved researchers looking into a vaporized weed formula with 13% CBD and 9% THC, and its effects on 69 patients with multiple sclerosis. The participants had varying symptoms, including muscle spasticity, bladder dysfunction, and disability progressions, all of which were analyzed at baseline levels to be evaluated again at three then six months. According to the researchers, “Significant improvement was observed across all outcome assessments,” after the patients were given vaporized weed.
New Jersey’s THC beverage market is heading into the most consequential stretch of its short…
Mormon Wives star Mikayla Matthews says medical cannabis was “literally life-changing” for her nerve pain…
Chains reorder every two weeks and earn twice the discounts. Independents stock the same breadth…
We head to Canna Country Farms in Humboldt for Legendary Strains to discover the Ocimene…
Cannabis advocates should take the lesson here too. The industry doesn't need to inflate its…
Twenty patient associations from across northeastern Brazil are meeting in Fortaleza this month, inside a…